Position paper about isotretinoin on acne vulgaris

Main Article Content

Minerva Gómez-Flores
<p>Servicio de Dermatolog&iacute;a, Hospital Universitario &ldquo;Jos&eacute; Eleuterio Gonz&aacute;lez&rdquo;. Monterrey, Nuevo Le&oacute;n</p>

Linda García-Hidalgo
<p>Departamento de Dermatolog&iacute;a, Instituto Nacional de Ciencias M&eacute;dicas y Nutrici&oacute;n &ldquo;Salvador Zubir&aacute;n&quot;, Secretar&iacute;a de Salud. Distrito Federal</p>

Leonel Fierro-Arias
<p>Servicio de Dermatolog&iacute;a, Hospital General de M&eacute;xico, Secretar&iacute;a de Salud. Distrito Federal</p>

Javier Ruiz-Ávila
<p>Derm&eacute;dica. Distrito Federal</p>

Maira Herz-Ruelas
<p>Servicio de Dermatolog&iacute;a, Hospital Universitario &ldquo;Jos&eacute; Eleuterio Gonz&aacute;lez&rdquo;. Monterrey, Nuevo Le&oacute;n</p>

Jorge Garza-Gómez
<p>Servicio de Dermatolog&iacute;a, Hospital Universitario &ldquo;Jos&eacute; Eleuterio Gonz&aacute;lez&rdquo;. Monterrey, Nuevo Le&oacute;n</p>

Keywords

Isotretinoin, Acne vulgaris

Abstract

Isotretinoin was authorized since 1982 for the treatment of acne vulgaris associated to severe cutaneous lesions. It has been used in others clinical conditions in various plans of prescription. Since the Isotretinoin was launched, it caused controversies in our country and around the world, especially in relation with the security. Isotretinoin is proscribed in pregnant patient. As a security rule we must measure serum lipids and hepatic enzymes. The aim of the consensus was to spread information worked by a group of Mexican experienced dermatologists to the health professionals about the use and the specific indications about isotretinoin.

Abstract 133 | PDF (Spanish) Downloads 228

References

Goldsmith LA, Bolognia JL, Callen JP, Chen SC, Feldman SR, Lim HW, et al. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol 2004;50(6):900-906.

 

Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001;45(5):S150-157.

 

Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med 1985;313(14):837-841.

 

Mitchell AA, Van Bennekom CM, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995;333(2):101-106.

 

Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician 2000;62 (8):1823-1830,1835-1836.

 

Strauss JS, Gottlieb AB, Jones T, Koo JY, Leyden JJ, Lucky A, et al. Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial. J Am Acad Dermatol 2000;43(5 Pt 1):777-784.

 

Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg 2000;4(2):66-70.

 

Byrne A, Hnatko G. Depression associated with isotretinoin therapy [letter]. Can J Psychiatry 1995; 40(9):567.

 

Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin.J Am Acad Dermatol 2001;45(4):515-519.

 

Kunynetz RA. A review of systemic retinoid therapy for acne and related conditions. Skin Therapy Lett 2004;9(3):1-4. Disponible en http://www.skintherapyletter.com/2004/9.3/1.html

 

Hernández-Pérez E, Khawaja HA, Álvarez TY. Oral isotre-tinoin as part of the treatment of cutaneous aging. Dermatol Surg 2000;26(7):649-652.

 

Kalil CL, Fachinello FZ, Lamb FM, Comunello LN. Use of oral isotretinoin in photoaging therapy. Skinmed 2008;7 (1):10-14.

 

Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45(4):515-519.

 

Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001;45(5):S150-S157.

 

Reddy D, Siegel CA, Sands BE, Kane S. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006;101(7):1569-1573.

 

Passier JL, Srivastava N, van Puijenbroek EP. Isotretinoin-induced inflammatory bowel disease. Neth J Med 2006; 64(2):52-54.

 

Mora JR. Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. Inflamm Bowel Dis 2008;14(2):275-289. Disponible en http://onlinelibrary.wiley. com/doi/10.1002/ibd.20280/pdf 

 

Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005;54(9):1232-1236. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774672/?tool=pubmed

 

Layton MA, Stainforth JM, Cunliffe WJ. Ten years' experience of oral isotretinoin for the treatment of acne vulgaris. J Dermatol Treat 1992;4 (Supl 2):2-5.

 

Sladden MJ, Harman KE. What is the chance of a normal pregnancy in a woman whose fetus has been exposed to isotretinoin? Arch Dermatol 2007;143(9):1187-1188. 

 

Berard A, Azoulay L, Koren G, Blais L, Perreault S, Oraich D. Isotretinoin, pregnancies, abortions, and birth defects: a population-based perspective. Br J Clin Pharmacol 2007; 63(2):196-205. Disponible en http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125. 2006.02837.x/pdf

Article Sidebar

PDF (Spanish)
Issue
Vol. 49 No. 3 (2011): May-June
Section
Temas de actualidad

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.

How to Cite

1.
Gómez-Flores M, García-Hidalgo L, Fierro-Arias L, Ruiz-Ávila J, Herz-Ruelas M, Garza-Gómez J. Position paper about isotretinoin on acne vulgaris. Rev Med Inst Mex Seguro Soc [Internet]. 2017 Jul. 10 [cited 2025 Jul. 15];49(3):281-8. Available from: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/1625